NCT01445132View on ClinicalTrials.gov

Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 11, 2007

Primary Completion Date

April 24, 2013

Study Completion Date

April 24, 2013

Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG

Allogeneic Cell Therapy w/ Tumor-derived Lypho

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01445132 - Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation | Biotech Hunter | Biotech Hunter